IART - インテグラ・ライフサイエンシズ・ホ―ルディングス (Integra LifeSciences Holdings Corporation) インテグラ・ライフサイエンシズ・ホ―ルディングス

 IARTのチャート


 IARTの企業情報

symbol IART
会社名 Integra LifeSciences Holdings Corp (インテグラ・ライフサイエンシズ・ホ―ルディングス)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 インテグラ・ライフサイエンス・ホールディングズ(Integra LifeSciences Holdings Corporation)は医療技術会社である。同社は外科用インプラントと医療機器の開発、製造、マーケティングに従事する。同社のセグメントには脳神経外科手術室と救命救急部に使用される製品ポートフォリオを含む専門設備を提供する特殊外科手術用ソリューション、差別化軟組織修復および組織再生製品、小さな骨固定と関節置換ソリューションを含む整形外科および組織技術により構成される。同社は硬膜修復、精密器具、組織アブレーションおよび神経的ケア用の製品および溶液を販売する。同社はまた熱傷等の急性創傷と糖尿病性足潰瘍と手術組織修復などの慢性創傷を治療するための再生技術製品を販売する。同社の製品は脳神経外科手術、四肢の再建手術、整形外科および一般手術に使用される。   インテグラ・ライフサイエンシズ・ホ―ルディングスは、医療機器を提供する米国の持株会社。外科用インプラント及び医療機器の開発、製造、販売に従事。主に脳神経外科、神経救命診療、整形外科、脊椎治療などの分野に製品を提供。米国はじめ、カナダ、欧州、中東、アフリカ、中南米、アジア、オ―ストラリア、ニュ―ジ―ランドなどで、世界的に事業を展開。   Integra LifeSciences Holdings Corp. engages in the manufacture and sale of medical instruments, devices, and equipment. It operates through the Codman Specialty Surgical, and Orthopedics and Tissue Technologies segments. The Codman Specialty Surgical segment refers to the company's neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and precision tools and instruments business, which sells instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices. The Orthopedics and Tissue Technologies segment includes offerings such as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
本社所在地 311 Enterprise Drive Plainsboro NJ 08536 USA
代表者氏名 Stuart M. Essig スチュアート・エシグ
代表者役職名 Independent Chairman of the Board
電話番号 +1 609-275-0500
設立年月日 32660
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 4400人
url www.integralife.com
nasdaq_url https://www.nasdaq.com/symbol/iart
adr_tso
EBITDA EBITDA(百万ドル) 317.48100
終値(lastsale) 61.27
時価総額(marketcap) 5216010681.2
時価総額 時価総額(百万ドル) 5327.533
売上高 売上高(百万ドル) 1370.708
企業価値(EV) 企業価値(EV)(百万ドル) 6620.25
当期純利益 当期純利益(百万ドル) 113.28200
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Integra Lifesciences Holdings Corp revenues increased 34% to $723.3M. Net income increased 30% to $22.4M. Revenues reflect Specialty Surgical Solutions segment increase from $159.9M to $475.6M Orthopedics and Tissue Technologies segment increase from $122.3M to $247.7M United States segment increase from $219.3M to $508.6M Europe segment increase from $32.5M to $103.2M.

 IARTのテクニカル分析


 IARTのニュース

   Medical Implants Market Industry Analysis, Scope, Covid-19 Reports, Trends, Regional Analysis, Business-Opportunities 2025 | Johnson & Johnson, Integra Lifesciences Holdings Corporation, Medtronic.  2020/11/11 19:18:01 OpenPR
Medical Implants Market is expected to garner $116 billion by 2022. Medical implants are medical devices or tissues that are surgically transplanted inside the body. The major factors boosting the market growth include technological advancements [such as bioabsorbable stents], rising incidence
   Osteonecrosis Treatment Market Analysis by Atnahs, Teva Pharmaceutical Industries Ltd, Mylan N.V, Integra LifeSciences Corporation  2020/11/11 18:26:43 OpenPR
Osteonecrosis Treatment Market By Therapy (Stem Cell Therapy, Joint Replacement Therapy), Treatment (Medication, Surgery), Route of Administration (Oral and Parenteral), Distribution Channel (Direct, Online Pharmacy, Retailers and Others), End-Users (Hospitals, Homecare, Specialty Clinics and Others), Geography (North America, Europe, Asia-Pacific,
   Extremity Reconstruction Market Product Functional Survey 2025 | Arthrex, Inc., DePuy Synthes, Integra Lifesciences Holdings Corporation  2020/11/06 11:40:14 OpenPR
Global Extremity Reconstruction Market: Snapshot Extremity reconstruction implies the restoration of limbs and limb functions to patients who have suffered the removal of limbs due to trauma or medical removal after cancer or other issues. This also includes limb removal after
   Global Artificial Tendons and Ligaments Market 2020:Overview, Outlook, Recent Trend,Covid-19 Impact on Market Size,Growth Factors,Key Players-LARS, Neoligaments, Artelon, GROUP FH ORTHO communication, Integra LifeSciences Corporation  2020/11/03 09:39:16 OpenPR
Artificial Tendons and Ligaments market report provides an orderly estimation of the key challenges in terms of sales, export/import, or revenue that any business may have to face in the coming years. While structuring this market research report, plentiful of
   Amniotic Band Syndrome Market 2020 Key Country Analysis: DESTACO, Medtronic, Integra LifeSciences Corporation, Galatea Surgical, Smiths Group plc  2020/11/02 19:03:46 OpenPR
The Amniotic Band Syndrome Market report makes available a profound overview of product specification, technology, product type and production analysis considering major factors such as revenue, cost, and gross margin. All the data, statistics, and information brought together in the report has
   Global Digits Replacement Industry 2015-2030 and Impact of COVID-19 with Rank/Share Analysis of Integra LifeSciences, Stryker, Wright Medical Group and KLS Martin - ResearchAndMarkets.com  2020/08/12 16:22:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Digits Replacement (Orthopedic Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering. This market model discusses in detail the impact of COVID-19 on Digits Replacement market for the year 2020 and beyond. Companies Mentioned Integra LifeSciences Corp. Stryker Corp. Wright Medical Group N.V. KLS Martin L.P. Although fusion is often still considered the treatment of choice the new ge
   Integra LifeSciences Holdings EPS beats by $0.19, beats on revenue (NASDAQ:IART)  2020/08/10 20:03:57 Seeking Alpha
Integra LifeSciences Holdings (NASDAQ:IART): Q2 Non-GAAP EPS of $0.33 beats by $0.19; GAAP EPS of $0.00 beats by $0.13. Revenue of $258.67M (-32.6% Y/Y) be
   Integra LifeSciences Reports Second Quarter 2020 Financial Results  2020/08/10 20:01:00 GlobeNewswire
PRINCETON, N.J., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company,…
   Integra Lifesciences Earnings Preview  2020/08/07 10:57:00 Benzinga
On Monday, August 10, Integra Lifesciences (NASDAQ: IART) will release its latest earnings report. Benzinga's outlook for Integra Lifesciences is …
   Worldwide Interventional Spine Devices Market (2020 to 2024) - Featuring Alphatec Holdings, Globus Medical & Integra LifeSciences Among Others - ResearchAndMarkets.com  2020/08/05 15:52:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Global Interventional Spine Devices Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The interventional spine devices market is poised to grow by $ 2.31 bn during 2020-2024 progressing at a CAGR of 10% during the forecast period. The report on the interventional spine devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The r
   Global Total Ankle Replacement Market (2020 to 2026) - Key Players Include Stryker, Integra LifeSciences & Exactech Among Others - ResearchAndMarkets.com  2020/07/22 14:52:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Global Total Ankle Replacement Market 2020-2026" report has been added to ResearchAndMarkets.com's offering. The global total ankle replacement market is estimated to witness significant growth during the forecast period. Some key factors encouraging the market growth include the rising geriatric population and increasing demand for minimally invasive joint replacement procedures. There is a significant rise in the geriatric population, which results in the increas
   Integra LifeSciences Receives FDA Clearance for Specific Neurosurgery Indication for CUSA® Clarity  2020/07/22 12:00:00 GlobeNewswire
First and Only Ultrasonic Tissue Ablation System Cleared to Treat Malignant and Benign Tumors, but Not Limited to Meningiomas and Gliomas
   Integra LifeSciences sees 34% drop in Q2 revenue due to pandemic disruptions (NASDAQ:IART)  2020/07/09 20:23:27 Seeking Alpha
On a preliminary basis, Integra LifeSciences (NASDAQ:IART) expects Q2 revenues of $254M - 256M, down ~34% from a year ago. On a more positive note, average
   Integra LifeSciences Announces Preliminary Second Quarter Revenue Results; Will Host Second Quarter 2020 Financial Results Conference Call on August 10, 2020  2020/07/09 20:15:00 GlobeNewswire
PRINCETON, N.J., July 09, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company,…
   Integra (IART) Up 8.6% Since Last Earnings Report: Can It Continue?  2020/06/06 15:31:52 Zacks Investment Research
Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 インテグラ・ライフサイエンシズ・ホ―ルディングス IART Integra LifeSciences Holdings Corporation)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)